238 related articles for article (PubMed ID: 38183981)
1. Antitumor efficacy of a sequence-specific DNA-targeted γPNA-based c-Myc inhibitor.
Malik S; Pradeep SP; Kumar V; Xiao Y; Deng Y; Fan R; Vasquez JC; Singh V; Bahal R
Cell Rep Med; 2024 Jan; 5(1):101354. PubMed ID: 38183981
[TBL] [Abstract][Full Text] [Related]
2. Targeting a KRAS i-motif forming sequence by unmodified and gamma-modified peptide nucleic acid oligomers.
Sarkar S; Colón-Roura G; Pearse A; Armitage BA
Biopolymers; 2023 Jan; 114(1):e23529. PubMed ID: 36573547
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Hybridization Selectivity Using Structured GammaPNA Probes.
Canady TD; Berlyoung AS; Martinez JA; Emanuelson C; Telmer CA; Bruchez MP; Armitage BA
Molecules; 2020 Feb; 25(4):. PubMed ID: 32098111
[TBL] [Abstract][Full Text] [Related]
4. Chimeric γPNA-Invader probes: using intercalator-functionalized oligonucleotides to enhance the DNA-targeting properties of γPNA.
Emehiser RG; Hrdlicka PJ
Org Biomol Chem; 2020 Feb; 18(7):1359-1368. PubMed ID: 31984413
[TBL] [Abstract][Full Text] [Related]
5. Constraining TAT Peptide by γPNA Hairpin for Enhanced Cellular Delivery of Biomolecules.
Thennakoon S; Postema R; Tan X
Methods Mol Biol; 2021; 2355():265-273. PubMed ID: 34386964
[TBL] [Abstract][Full Text] [Related]
6. Film-Spotting chiral miniPEG-γPNA array for BRCA1 gene mutation detection.
Dong B; Nie K; Shi H; Chao L; Ma M; Gao F; Liang B; Chen W; Long M; Liu Z
Biosens Bioelectron; 2019 Jul; 136():1-7. PubMed ID: 31026759
[TBL] [Abstract][Full Text] [Related]
7. Head on Comparison of Self- and Nano-assemblies of Gamma Peptide Nucleic Acid Amphiphiles.
Malik S; Kumar V; Liu CH; Shih KC; Krueger S; Nieh MP; Bahal R
Adv Funct Mater; 2022 Feb; 32(7):. PubMed ID: 35210986
[TBL] [Abstract][Full Text] [Related]
8. Peptide nucleic acids: on the road to new gene therapeutic drugs.
Nielsen PE
Pharmacol Toxicol; 2000 Jan; 86(1):3-7. PubMed ID: 10720100
[TBL] [Abstract][Full Text] [Related]
9. Closing the Loop: Constraining TAT Peptide by γPNA Hairpin for Enhanced Cellular Delivery of Biomolecules.
Tan X; Bruchez MP; Armitage BA
Bioconjug Chem; 2018 Sep; 29(9):2892-2898. PubMed ID: 30130094
[TBL] [Abstract][Full Text] [Related]
10. Strand invasion of extended, mixed-sequence B-DNA by gammaPNAs.
He G; Rapireddy S; Bahal R; Sahu B; Ly DH
J Am Chem Soc; 2009 Sep; 131(34):12088-90. PubMed ID: 19663424
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy.
Tonelli R; McIntyre A; Camerin C; Walters ZS; Di Leo K; Selfe J; Purgato S; Missiaglia E; Tortori A; Renshaw J; Astolfi A; Taylor KR; Serravalle S; Bishop R; Nanni C; Valentijn LJ; Faccini A; Leuschner I; Formica S; Reis-Filho JS; Ambrosini V; Thway K; Franzoni M; Summersgill B; Marchelli R; Hrelia P; Cantelli-Forti G; Fanti S; Corradini R; Pession A; Shipley J
Clin Cancer Res; 2012 Feb; 18(3):796-807. PubMed ID: 22065083
[TBL] [Abstract][Full Text] [Related]
12. Dihydrotestosterone as a selective cellular/nuclear localization vector for anti-gene peptide nucleic acid in prostatic carcinoma cells.
Boffa LC; Scarfi S; Mariani MR; Damonte G; Allfrey VG; Benatti U; Morris PL
Cancer Res; 2000 Apr; 60(8):2258-62. PubMed ID: 10786693
[TBL] [Abstract][Full Text] [Related]
13. Targeting of cancer-related proteins with PNA oligomers.
Pooga M; Langel U
Curr Cancer Drug Targets; 2001 Nov; 1(3):231-9. PubMed ID: 12188881
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5.
Bahal R; McNeer NA; Ly DH; Saltzman WM; Glazer PM
Artif DNA PNA XNA; 2013; 4(2):49-57. PubMed ID: 23954968
[TBL] [Abstract][Full Text] [Related]
15. Single-stranded γPNAs for in vivo site-specific genome editing via Watson-Crick recognition.
Bahal R; Quijano E; McNeer NA; Liu Y; Bhunia DC; Lopez-Giraldez F; Fields RJ; Saltzman WM; Ly DH; Glazer PM
Curr Gene Ther; 2014; 14(5):331-42. PubMed ID: 25174576
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Reversible Translation Control Using γPNA Probes.
Canady TD; Telmer CA; Oyaghire SN; Armitage BA; Bruchez MP
J Am Chem Soc; 2015 Aug; 137(32):10268-75. PubMed ID: 26241615
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of chiral gammaPNA with complementary DNA strand: insights into the stability and specificity of recognition and conformational preorganization.
Yeh JI; Shivachev B; Rapireddy S; Crawford MJ; Gil RR; Du S; Madrid M; Ly DH
J Am Chem Soc; 2010 Aug; 132(31):10717-27. PubMed ID: 20681704
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Potential of Chemically Modified, Synthetic, Triplex Peptide Nucleic Acid-Based Oncomir Inhibitors for Cancer Therapy.
Dhuri K; Gaddam RR; Vikram A; Slack FJ; Bahal R
Cancer Res; 2021 Nov; 81(22):5613-5624. PubMed ID: 34548334
[TBL] [Abstract][Full Text] [Related]
19. Circular dichroism study of DNA binding by a potential anticancer peptide nucleic acid targeted against the MYCN oncogene.
Faccini A; Tortori A; Tedeschi T; Sforza S; Tonelli R; Pession A; Corradini R; Marchelli R
Chirality; 2008 Mar; 20(3-4):494-500. PubMed ID: 17963203
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor Activity of miniPEG-γ-Modified PNAs to Inhibit MicroRNA-210 for Cancer Therapy.
Gupta A; Quijano E; Liu Y; Bahal R; Scanlon SE; Song E; Hsieh WC; Braddock DE; Ly DH; Saltzman WM; Glazer PM
Mol Ther Nucleic Acids; 2017 Dec; 9():111-119. PubMed ID: 29246289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
